Ivan C Rokos
Overview
Explore the profile of Ivan C Rokos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Mahmud E, Dauerman H, Welt F, Messenger J, Rao S, Grines C, et al.
J Am Coll Cardiol
. 2020 Apr;
76(11):1375-1384.
PMID: 32330544
The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between...
3.
Mahmud E, Dauerman H, Welt F, Messenger J, Rao S, Grines C, et al.
Catheter Cardiovasc Interv
. 2020 Apr;
96(2):336-345.
PMID: 32311816
The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association...
4.
Hsia R, Sabbagh S, Sarkar N, Sporer K, Rokos I, Brown J, et al.
West J Emerg Med
. 2018 May;
19(3):630.
PMID: 29762612
[This corrects the article on p. 1010 in vol. 18, PMID: 29085531.].
5.
Hsia R, Sabbagh S, Sarkar N, Sporer K, Rokos I, Brown J, et al.
West J Emerg Med
. 2017 Nov;
18(6):1010-1017.
PMID: 29085531
Introduction: California has led successful regionalized efforts for several time-critical medical conditions, including ST-segment elevation myocardial infarction (STEMI), but no specific mandated protocols exist to define regionalization of care. We...
6.
Lange D, Rokos I, Garvey J, Larson D, Henry T
Interv Cardiol Clin
. 2017 Jun;
5(4):451-469.
PMID: 28581995
First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of...
7.
Fordyce C, Al-Khalidi H, Jollis J, Roettig M, Gu J, Bagai A, et al.
Circ Cardiovasc Interv
. 2017 Jan;
10(1).
PMID: 28082714
Background: The Mission: Lifeline STEMI Systems Accelerator program, implemented in 16 US metropolitan regions, resulted in more patients receiving timely reperfusion. We assessed whether implementing key care processes was associated...
8.
Lange D, Rokos I, Larson D, Sharkey S, French W, Koenig W, et al.
Rev Cardiovasc Med
. 2016 Sep;
17(1-2):1-6.
PMID: 27667375
Over the past 20 years, care for patients with ST-elevation myocardial infarction (STEMI) has rapidly evolved, not just in terms of how patients are treated, but where patients are treated....
9.
Jollis J, Al-Khalidi H, Roettig M, Berger P, Corbett C, Dauerman H, et al.
Circulation
. 2016 Aug;
134(5):365-74.
PMID: 27482000
Background: Up to 50% of patients fail to meet ST-segment-elevation myocardial infarction (STEMI) guideline goals recommending a first medical contact-to-device time of <90 minutes for patients directly presenting to percutaneous...
10.
Rokos I, Sporer K, Savino P, Mercer M, Shontz S, Sabbagh S, et al.
Crit Pathw Cardiol
. 2016 Jul;
15(3):103-5.
PMID: 27465005
Introduction: California has been a global leader in regionalization efforts for time-critical medical conditions. A total of 33 local emergency medical service agencies (LEMSAs) exist, providing an organized EMS framework...